1 to 10 of 28 literature results

• Are the pleiotropic effects of drugs used for the prevention of cardiovascular disease clinically relevant?

  Authors: Moses Elisaf, Evangelos N Liberopoulos

  Source: Current pharmaceutical design. 2009

  View Full Text

• Multiple actions of high-density lipoprotein.

  PURPOSE OF REVIEW: The most accepted property of high-density lipoprotein is reverse cholesterol transport. However, other beneficial actions may cont…

  Authors: Matilda Florentin, Evangelos N Liberopoulos, Anthony S Wierzbicki, Dimitri P Mikhailidis

  Source: Current opinion in cardiology. 2008 Jul

  View Full Text

• Persistent erythema multiforme in a patient with extrahepatic cholangiocarcinoma.

  Presented in this report is a 66-year-old male with a widespread persistent erythema multiforme mostly atypical in appearance, which was detected well…

  Authors: Vasilios Tzovaras, Evangelos N Liberopoulos, Aikaterini Zioga, Nikolas Pavlidis, Moses Elisaf

  Source: Oncology. 2007

  View Full Text

• Identifying and attaining LDL-C goals: mission accomplished? Next target: new therapeutic options to raise HDL-C levels.

  Currently, low density lipoprotein cholesterol (LDL-C) levels are the main, if not the only, lipid target in the effort to reduce cardiovascular disea…

  Authors: Vasilios G Athyros, Dimitri P Mikhailidis, Anna I Kakafika, Asterios Karagiannis, Apostolos Hatzitolios, Konstantinos Tziomalos, Emmanuel S Ganotakis, Evangelos N Liberopoulos, Moses Elisaf

  Source: Current drug targets. 2007 Mar

  View Full Text

• Diverging trends in cardiovascular morbidity and mortality in a low risk population.

  Cardiovascular (CVD) disease morbidity and mortality are changing over the years, following changes in socioeconomic conditions and underlying risk fa…

  Authors: Theodore Chimonas, Irene Fanouraki, Evangelos N Liberopoulos, Elias Chimonas, Moses Elisaf

  Source: European journal of epidemiology. 2009

  View Full Text

• Prevalence of vascular disease in metabolic syndrome using three proposed definitions.

  BACKGROUND: There are a number of definitions available for the diagnosis of the metabolic syndrome (MetS). The MetS-associated increase in cardiovasc…

  Authors: Vasilios G Athyros, Emmanuel S Ganotakis, Moses S Elisaf, Evangelos N Liberopoulos, Ioannis A Goudevenos, Asterios Karagiannis, GREECE-METS Collaborative Group

  Source: International journal of cardiology. 2007 Apr 25

  View Full Text

• The hypertriglyceridemic waist phenotype is a predictor of elevated levels of small, dense LDL cholesterol.

  The hypertriglyceridemic waist (HTGW) phenotype (hypertriglyceridemia and increased waist circumference) has been proposed as an inexpensive tool to m…

  Authors: Irene F Gazi, Theodosios D Filippatos, Vasilis Tsimihodimos, Vasilios G Saougos, Evangelos N Liberopoulos, Dimitri P Mikhailidis, Alexandros D Tselepis, Moses Elisaf

  Source: Lipids. 2006 Jul

  View Full Text

• Upper gastrointestinal haemorrhage complicating antiplatelet treatment with aspirin and/or clopidogrel: where we are now?

  A large number of patients require antiplatelet therapy (mainly aspirin and/or clopidogrel). Recent studies suggest that the combination of these agen…

  Authors: Evangelos N Liberopoulos, Moses S Elisaf, Alexandros D Tselepis, Athanasios Archimandritis, Dimitris Kiskinis, Dennis Cokkinos, Dimitri P Mikhailidis

  Source: Platelets. 2006 Feb

  View Full Text

• Effect of multifactorial treatment on non-alcoholic fatty liver disease in metabolic syndrome: a randomised study.

  BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome (MetS). There is no established treatment…

  Authors: Vasilios G Athyros, Dimitri P Mikhailidis, Triandafillos P Didangelos, Olga I Giouleme, Evangelos N Liberopoulos, Asterios Karagiannis, Anna I Kakafika, Konstantinos Tziomalos, Andrew K Burroughs, Moses S Elisaf

  Source: Current medical research and opinion. 2006 May

  View Full Text

• Statin pleiotropy against renal injury.

  Statins may exhibit significant renoprotective effects beyond their lipid-lowering capacity. Herein, the authors review data from human and animal mod…

  Authors: Michael S Kostapanos, Evangelos N Liberopoulos, Moses S Elisaf

  Source: Journal of the cardiometabolic syndrome. 2009

  View Full Text